These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24247)

  • 1. [Current status of diabetic microangiopathy].
    Mosora N; Hîncu N; Duţu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(6):513-8. PubMed ID: 24247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetic microangiopathy. Diagnosis and therapy].
    Standl E
    Med Welt; 1980 Jun; 31(24):920-2. PubMed ID: 7421518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pyridinolcarbamate in the treatment of peripheral vascular diseases in diabetics. Observations after 3 years of clinical use].
    Parodi FA
    Minerva Med; 1974 May; 65(40):2316-20. PubMed ID: 4421119
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic neuropathy.
    Gominak S; Parry GJ
    Adv Neurol; 2002; 88():99-109. PubMed ID: 11908239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)].
    Le Devehat C; Lemoine A
    Journ Annu Diabetol Hotel Dieu; 1977; ():389-93. PubMed ID: 894879
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiopathy in diabetes mellitus.
    Prusty P; Saini JS; Gandhi B; Prabhakar AR
    J Assoc Physicians India; 1995 Feb; 43(2):111-4. PubMed ID: 9282675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution of angioxine to the vascular protection of the diabetic].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA; Caputo G
    Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyridinolcarbamate in diabetic angiopathies].
    Indovina I; Furitano G; Notarbartolo A; Citarrella P; Scaffidi A
    Minerva Med; 1978 May; 69(24):1681-97. PubMed ID: 566399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes, coronary heart disease and sulphonylureas-not the final word.
    Betteridge DJ; Close L
    Eur Heart J; 2000 May; 21(10):790-2. PubMed ID: 10781346
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Toward prevention of diabetic microangiopathy.
    Vaisrub S
    JAMA; 1976 Mar; 235(11):1148-9. PubMed ID: 946219
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of pyridonolcarbamate in diabetic angiopathy].
    Furitano G; Cajozzo A; Notarbartolo A
    Minerva Med; 1975 Dec; 66(85):4599-602. PubMed ID: 1196545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antioxidants in the combined therapy of diabetic angiopathies].
    Bobyreva LE
    Eksp Klin Farmakol; 1998; 61(1):74-80. PubMed ID: 9575419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hydroxyproline indicators before and after treatment of diabetic angiopathies].
    Spesivtseva VG; Mamaeva GG; Starosel'tseva LK; Tulemisov EU; Bokaneva IA
    Ter Arkh; 1978; 50(1):93-7. PubMed ID: 635809
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
    Camera A; Hopps E; Caimi G
    Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
    Duhault J; Lebon F
    Arzneimittelforschung; 1972 Oct; 22(10):1686-90. PubMed ID: 4677057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current aspects of the mechanism of action of calcium antagonists in patients with diabetes mellitus].
    Kostiuk OP; Zubkova ST
    Fiziol Zh (1978); 1992; 38(3):106-11. PubMed ID: 1499754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report.
    Girolami A; Peruffo R; Emanueli A
    Arzneimittelforschung; 1977; 27(6):1202. PubMed ID: 578441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.